Barthalomew Wilson
Barthalomew Wilson is an emerging global health researcher with over ten years of experience in infectious disease research, epidemic response, and community engagement in outbreak-prone and resource-limited settings. He specializes in qualitative, mixed-methods, and ethnographic research and is passionate about bridging science and society through inclusive, ethical, and community-driven approaches.
Barthalomew is currently pursuing a PhD in Global Health Research at Maastricht University, focusing on the socioeconomic impact of COVID-19 and vaccine acceptance in Liberia. He holds a Master of Medical Science in Global Health Delivery from Harvard Medical School and is a NYU-UG Research Integrity Training Program Fellow, co-leading a project on intellectual property rights and research benefit-sharing in Ebola-related studies conducted in Liberia.
As Social Mobilization, Communications, and Community Engagement Manager for the U.S.-Liberia Joint Clinical Research Program (PREVAIL), Barthalomew designed and implemented Good Participatory Practice (GPP) strategies for multiple clinical trials and observational studies. He is skilled in ethical community engagement, risk communication, and participatory practices for emerging pathogens, with a strong commitment to promoting community participation and ensuring trust and transparency in research and public health interventions.